Study shows value of breast cancer patients seeking second opinions

Breast scan
In a recent study on the value of a second opinion for breast cancer patients, researchers concluded that a review by a tumor board at an NCI-Designated Cancer Center changed the diagnosis for 43 percent of the patients.

Surgical Oncologist Nancy DeMore, M.D., of the Hollings Cancer Center, knows the value of a multidisciplinary tumor board. It’s one reason she and colleagues decided to conduct a study.

Published in the Annals of Surgical Oncology, the study looked at the value of a second opinion for breast cancer patients referred to a National Cancer Institute-Designated Cancer Center with a tumor board. Researchers concluded that a review by a multidisciplinary tumor board at an NCI-Designated Cancer Center changed the diagnosis for 43 percent of the patients who presented for a second opinion for breast cancer.

Full Story: Study shows value of breast cancer patients seeking second opinions